LEADER 01664oam  2200457 a 450 
001 9910696982603321
005 20230902161720.0
035   $a(CKB)5470000002383063
035   $a(OCoLC)529901740
035   $a(EXLCZ)995470000002383063
100   $a20100226d2010      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPreserve Access to Affordable Generics Act$b[electronic resource] $ereport together with minority views (to accompany S. 369) (including cost estimate of the Congressional Budget Office)
210  1$a[Washington, D.C.] :$c[U.S. G.P.O.],$d[2010]
215   $a1 online resource (43 pages)
225 1 $aReport / 111th Congress, 2d session, Senate ;$v111-123
300   $aTitle from title screen (viewed on Feb. 26, 2010).
300   $a"February 2, 2010."
320   $aIncludes bibliographical references.
517   $aPreserve Access to Affordable Generics Act 
606   $aDrugs$xPrices$xLaw and legislation$zUnited States
606   $aGeneric drugs$xPrices$xGovernment policy$zUnited States
606   $aDrugs$xLaw and legislation$zUnited States
606   $aCompetition, Unfair$zUnited States
615  0$aDrugs$xPrices$xLaw and legislation
615  0$aGeneric drugs$xPrices$xGovernment policy
615  0$aDrugs$xLaw and legislation
615  0$aCompetition, Unfair
801  0$bGPO
801  1$bGPO
801  2$bGPO
801  2$bUBY
801  2$bGPO
906   $aBOOK
912   $a9910696982603321
996   $aPreserve Access to Affordable Generics Act$93504346
997   $aUNINA